None
Conditions
Interventions
glabridin soft Capsule, 100mg/day, 12 weeks.
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The subjects are healthy 20-65 years old person
Exclusion criteria
Exclusion criteria: 1.Subjects under medication. 2.Subjects taking medicine and food that might impact the outcome measures. 3.Patients with serious disease such as renal disease, heart disease, respiratory illness, internal secretion disease, diabetes 4.Subjects who has allergy to experimental diet. 5.Subjects who are under treatment for or have a history of drug addiction and/or alcoholism. 6.Subjects who has metal in the body wherethe CT scanning measurement position 7.Susbjects who has implantable meicalequipments such as pacemaker and defibrillator. 8.Subjects who has Claustrophobia. 9.Shift workers, late-night workers 10.Subjects who have been diagnosed with familial. 11.Subjects who are planning to become pregnant during the study or are pregnant or lactating. 12.Subjects who are participating or planning to participate in other clinical studies to examine effects of food, medicine or cosmetics. 13.Subjects who are judged as unsuitable for the study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| visceral fat area | — |
Secondary
| Measure | Time frame |
|---|---|
| body weight, body fat percentage, abdominal subcutanious fat area, abdominal total fat area, Waist circumference, hip circumference, circumference hip waist circumference ratio, CHO, LDL, HDL, triglyceride, fasting blood glucose, HbA1c, insuliin, adiponectin, AST,ALT,HOMA-R | — |
Countries
Japan
Contacts
Public ContactYoshika Komori
KSO Corporation Sales department
Outcome results
None listed